Is Chemerin associated with gestational diabetes mellitus? An evidence-based clinical research from Chinese women

References

• Association AD. 2011. Executive summary: standards of medical care in diabetes—2011. Diabetes Care 34(Suppl 1):S4–S10.
   PubMed Web of Science ®Google Scholar
• Barker G, Lim R, Rice GE, Lappas M. 2012. Increased Chemerin concentrations in fetuses of obese mothers and correlation with maternal insulin sensitivity. Journal of Maternal-Fetal & Neonatal Medicine 25:2274–2280.
   PubMed Web of Science ®Google Scholar
• Baz B, Riveline J, Gautier J. 2016. Gestational diabetes mellitus: definition, aetiological and clinical aspects. European Journal of Endocrinology 174:R43–R51.
   PubMed Web of Science ®Google Scholar
• Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. 2007. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148:4687–4694.
   PubMed Web of Science ®Google Scholar
• Evensen AE. 2012. Update on gestational diabetes mellitus. Primary Care 39:83–94.
   PubMed Web of Science ®Google Scholar
• Fatima SS, Rehman R, Baig M, Khan TA. 2014. New roles of the multidimensional adipokine: Chemerin. Peptides 62:15–20.
   PubMed Web of Science ®Google Scholar
• Guo S. 2014. Insulin signaling, resistance, and metabolic syndrome. Insights from mouse models into disease mechanisms. Journal Endocrinology 220:T1–T23.
   PubMed Web of Science ®Google Scholar
• Hare KJ, Bonde L, Svare JA, Randeva HS, Asmar M, Larsen S, et al. 2014. Decreased plasma Chemerin levels in women with gestational diabetes mellitus. Diabetic Medicine 31:936–940.
   PubMed Web of Science ®Google Scholar
• Huang Z, Xie X. 2015. Chemerin induces insulin resistance in C2C12 cells through nuclear factor-κB pathway-mediated inflammatory reaction. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31:725–729.
   PubMedGoogle Scholar
• Issa ME, Muruganandan S, Ernst MC, Parlee SD, Zabel BA, Butcher EC, et al. 2012. Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis. American Journal of Physiology-Cell Physiology 302:C1621–C1631.
   PubMed Web of Science ®Google Scholar
• Lee J. 2013. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes. Archives of Pharmacal Research 36:208–222.
   PubMed Web of Science ®Google Scholar
• Li X, Ji H, Li C, Wang PH, Yu P, Yu DM. 2015. Chemerin expression in Chinese pregnant women with and without gestational diabetes mellitus. Annales D Endocrinologie 76:19–24.
   PubMed Web of Science ®Google Scholar
• Liu M, Xu X. 2012. Expression of Chemerin in peripheral plasma, umbilical vein and placenta of gestational diabetes mellitus. Progress in Obstetrics & Gynecology 21:391–394.
   Google Scholar
• Mariani F, Roncucci L. 2015. Chemerin/chemR23 axis in inflammation onset and resolution. Inflammation Research 64:85–95.
   PubMed Web of Science ®Google Scholar
• Mattern A, Zellmann T, Beck-Sickinger AG. 2014. Processing, signaling, and physiological function of Chemerin. IUBMB Life 66:19–26.
   PubMed Web of Science ®Google Scholar
• Mazaki-Tovi S, Kasher-Meron M, Hemi R, Haas J, Gat I, Lantsberg D, et al. 2012. Chemerin is present in human cord blood and is positively correlated with birthweight. American Journal of Obstetrics & Gynecology 207:412.e1–412.e.10.
   PubMed Web of Science ®Google Scholar
• Moses RG. 2012. Gestational diabetes mellitus: implications of an increased frequency with IADPSG criteria. Diabetes Care 35:461–462.
   PubMed Web of Science ®Google Scholar
• Nilsson C, Carlsson A, Landin-Olsson M. 2014. Increased risk for overweight among Swedish children born to mothers with gestational diabetes mellitus. Pediatric Diabetes 15:57–66.
   PubMed Web of Science ®Google Scholar
• Osman MM, Abd El-Mageed AI, El-hadidi E, Abeer I, El-hadidi E, et al. 2012. Clinical utility of serum Chemerin as a novel marker of metabolic syndrome and type 2 diabetes mellitus. Life Science Journal-Acta Zhengzhou University Overseas Edition 9:1098–1108.
   Google Scholar
• Pfau D, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, et al. 2010. Circulating levels of the adipokine Chemerin in gestational diabetes mellitus. Hormone Research in Paediatrics 74:56–61.
   PubMed Web of Science ®Google Scholar
• Rourke JL, Dranse HJ, Sinal CJ. 2013. Towards an integrative approach to understanding the role of Chemerin in human health and disease. Obesity Reviews 14:245–262.
   PubMed Web of Science ®Google Scholar
• Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, et al. 2009. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58:2731–2740.
   PubMed Web of Science ®Google Scholar
• Shao J, Liu M, Li F, Xu X. 2015. The expression of Chemerin in maternal peripheral, umbilical cord blood and placenta in gestational diabetic patients. Journal of Biomaterials and Tissue Engineering 5:833–837.
   Web of Science ®Google Scholar
• Takahashi M, Okimura Y, Iguchi G, Nishizawa H, Yamamoto M, Suda KM, et al. 2011. Chemerin regulates β-cell function in mice. Scientific Reports 1:123.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, et al. 2008. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters 582:573–578.
   PubMed Web of Science ®Google Scholar
• Tamayo T, Tamayo M, Rathmann W, Potthoff P. 2016. Prevalence of gestational diabetes and risk of complications before and after initiation of a general systematic two-step screening strategy in Germany (2012–2014). Diabetes Research and Clinical Practice 115:1–8.
   PubMed Web of Science ®Google Scholar
• van Poppel MNM, Zeck W, Ulrich D, Hirschmugl B, Lang U, Wadsack C, et al. 2014. Cord blood Chemerin: differential effects of gestational diabetes mellitus and maternal obesity. Clinical Endocrinology 80:65–72.
   PubMed Web of Science ®Google Scholar
• Vilmi-Kerälä T, Palomäki O, Vainio M, Uotila J, Palomäki A. 2015. The risk of metabolic syndrome after gestational diabetes mellitus – a hospital-based cohort study. Diabetology & Metabolic Syndrome 7:43.
   PubMed Web of Science ®Google Scholar
• Wieser V, Moschen AR, Tilg H. 2013. Inflammation, cytokines and insulin resistance: a clinical perspective. Archivum Immunologiae Et Therapiae Experimentalis 61:119–125.
   PubMed Web of Science ®Google Scholar
• Zhang R, Liu S, Guo B, Chang L, Li Y. 2014. Chemerin induces insulin resistance in rat cardiomyocytes in part through the erk1/2 signaling pathway. Pharmacology 94:259–264.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhang C. 2016. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Current Diabetes Reports 16:7.
   PubMed Web of Science ®Google Scholar